Merit Medical Systems, Inc’s filing revealed that its Officer RAUL PARRA acquired Company’s shares for reported $1.42 million on Jun 13 ’25. In the deal valued at $93.75 per share,15,181 shares were bought.
Then, Lampropoulos Fred P. sold 400 shares, generating $38,244 in total proceeds. Upon selling the shares at $95.61, the President and CEO now owns 1,045,628 shares.
Before that, FRED LAMPROPOULOS bought 400 shares. Merit Medical Systems, Inc shares valued at $38,244 were divested by the Officer at a price of $95.61 per share.
JP Morgan initiated its Merit Medical Systems, Inc [MMSI] rating to an Overweight in a research note published on March 28, 2025; the price target was $120. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who increased its forecast for the stock in mid December from “an Equal weight” to “an Overweight”. Robert W. Baird began covering MMSI with “an Outperform” recommendation on June 28, 2024. CL King started covering the stock on April 11, 2024. It rated MMSI as “a Buy”.
Price Performance Review of MMSI
On Friday, Merit Medical Systems, Inc [NASDAQ:MMSI] saw its stock fall -0.65% to $92.97. Over the last five days, the stock has lost -2.42%. Merit Medical Systems, Inc shares have fallen nearly -3.88% since the year began. Nevertheless, the stocks have risen 12.81% over the past one year. While a 52-week high of $111.45 was reached on 01/31/25, a 52-week low of $80.02 was recorded on 04/09/25.
Levels Of Support And Resistance For MMSI Stock
The 24-hour chart illustrates a support level at 92.13, which if violated will result in even more drops to 91.30. On the upside, there is a resistance level at 93.98. A further resistance level may holdings at 95.00.
How much short interest is there in Merit Medical Systems, Inc?
A steep rise in short interest was recorded in Merit Medical Systems, Inc stocks on 2025-05-30, growing by 0.13 million shares to a total of 3.41 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 3.28 million shares. There was a rise of 3.74%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 07, 2024 when BofA Securities began covering the stock and recommended ‘”a Neutral”‘ rating along with a $87 price target.
